SUMMARY OBJECTIVES: To examine sputum specimens from patients with persistent bronchopulmonary disorders for mycobacterium species and to characterize the recovered isolates with a view to determining the extent of involvement of environmental mycobacteria in pulmonary infections. DESIGN: Analytical study using standard microscopy, culture and biochemical test for the identification of mycobacterium species. SETTING: Jos University Teaching Hospital (JUTH) and 2 referral hospitals: Plateau Specialist Hospital and Evangelical Churches of West Africa (ECWA) Evangel Hospital in Jos, Nigeria. PARTICIPANTS: Three hundred and twenty nine (329) volunteer new patients seen at the chest clinic and general out patient departments with broncho-pulmonary disorders. Patients already on anti-tuberculosis were excluded from the study. INTERVENTIONS: Subjects were administered antituberculosis drugs and or other treatment regimes after proper diagnosis RESULTS: Sixty-five (65) mycobacterial isolates were obtained and differentiated into human tubercle bacilli, bovine and or environmental (atypical) mycobacteria on the basis of nine identification tests. Of the 65 mycobacterial isolates subjected to the tests, 40 (61.54%) were identified as mycobacterium tuberculosis, 10 (15.38%) as M. bovis and 15 (23.08%) as environmental mycobacteria. Among the environmental group, 9 (20.69%) were classified as M. avium 3 (3.45%) each as M. kansasi and M. fortuitum. CONCLUSIONS: The study confirms the involvement of bovine and environmental mycobacteria in pulmonary infections. This may be related to the rising prevalence of HIV/AIDS globally. The need for adequate bacteriological analysis in current-day diagnosis of pulmonary tuberculosis in indicated.
SUMMARY OBJECTIVES: To examine sputum specimens from patients with persistent bronchopulmonary disorders for mycobacterium species and to characterize the recovered isolates with a view to determining the extent of involvement of environmental mycobacteria in pulmonary infections. DESIGN: Analytical study using standard microscopy, culture and biochemical test for the identification of mycobacterium species. SETTING: Jos University Teaching Hospital (JUTH) and 2 referral hospitals: Plateau Specialist Hospital and Evangelical Churches of West Africa (ECWA) Evangel Hospital in Jos, Nigeria. PARTICIPANTS: Three hundred and twenty nine (329) volunteer new patients seen at the chest clinic and general out patient departments with broncho-pulmonary disorders. Patients already on anti-tuberculosis were excluded from the study. INTERVENTIONS: Subjects were administered antituberculosis drugs and or other treatment regimes after proper diagnosis RESULTS: Sixty-five (65) mycobacterial isolates were obtained and differentiated into human tubercle bacilli, bovine and or environmental (atypical) mycobacteria on the basis of nine identification tests. Of the 65 mycobacterial isolates subjected to the tests, 40 (61.54%) were identified as mycobacterium tuberculosis, 10 (15.38%) as M. bovis and 15 (23.08%) as environmental mycobacteria. Among the environmental group, 9 (20.69%) were classified as M. avium 3 (3.45%) each as M. kansasi and M. fortuitum. CONCLUSIONS: The study confirms the involvement of bovine and environmental mycobacteria in pulmonary infections. This may be related to the rising prevalence of HIV/AIDS globally. The need for adequate bacteriological analysis in current-day diagnosis of pulmonary tuberculosis in indicated.
Authors: R Krivinka; J Drápela; A Kubík; D Danková; J Krivánek; J Ruzha; Z Miková; E Hejdová Journal: Bull World Health Organ Date: 1974 Impact factor: 9.408
Authors: Linda M Parsons; Akos Somoskövi; Cristina Gutierrez; Evan Lee; C N Paramasivan; Alash'le Abimiku; Steven Spector; Giorgio Roscigno; John Nkengasong Journal: Clin Microbiol Rev Date: 2011-04 Impact factor: 26.132
Authors: Catherine Okoi; Suzanne T B Anderson; Martin Antonio; Sarah N Mulwa; Florian Gehre; Ifedayo M O Adetifa Journal: Sci Rep Date: 2017-09-20 Impact factor: 4.379
Authors: Clovice Kankya; Adrian Muwonge; Susan Olet; Musso Munyeme; Demelash Biffa; John Opuda-Asibo; Eystein Skjerve; James Oloya Journal: BMC Public Health Date: 2010-08-10 Impact factor: 3.295
Authors: Borna Müller; Salome Dürr; Silvia Alonso; Jan Hattendorf; Cláudio J M Laisse; Sven D C Parsons; Paul D van Helden; Jakob Zinsstag Journal: Emerg Infect Dis Date: 2013-06 Impact factor: 6.883
Authors: M De Garine-Wichatitsky; A Caron; R Kock; R Tschopp; M Munyeme; M Hofmeyr; A Michel Journal: Epidemiol Infect Date: 2013-04-15 Impact factor: 4.434